BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27117498)

  • 1. An analysis of tumor control probability of stereotactic body radiation therapy for lung cancer with a regrowth model.
    Tai A; Liu F; Gore E; Li XA
    Phys Med Biol; 2016 May; 61(10):3903-13. PubMed ID: 27117498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models.
    Liu F; Tai A; Lee P; Biswas T; Ding GX; El Naqa I; Grimm J; Jackson A; Kong FS; LaCouture T; Loo B; Miften M; Solberg T; Li XA
    Radiother Oncol; 2017 Feb; 122(2):286-294. PubMed ID: 27871671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal Radiation Therapy Fractionation Regimens for Early-Stage Non-Small Cell Lung Cancer.
    Liu F; Ververs JD; Farris MK; Blackstock AW; Munley MT
    Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):829-838. PubMed ID: 37734445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
    Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
    Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.
    Lee P; Loo BW; Biswas T; Ding GX; El Naqa IM; Jackson A; Kong FM; LaCouture T; Miften M; Solberg T; Tome WA; Tai A; Yorke E; Li XA
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):160-171. PubMed ID: 30954520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer.
    Guckenberger M; Klement RJ; Allgäuer M; Appold S; Dieckmann K; Ernst I; Ganswindt U; Holy R; Nestle U; Nevinny-Stickel M; Semrau S; Sterzing F; Wittig A; Andratschke N; Flentje M
    Radiother Oncol; 2013 Oct; 109(1):13-20. PubMed ID: 24183066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiobiological modeling of two stereotactic body radiotherapy schedules in patients with stage I peripheral non-small cell lung cancer.
    Huang BT; Lin Z; Lin PX; Lu JY; Chen CZ
    Oncotarget; 2016 Jun; 7(26):40746-40755. PubMed ID: 27203739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modified hypoxia-based TCP model to investigate the clinical outcome of stereotactic hypofractionated regimes for early stage non-small-cell lung cancer (NSCLC).
    Strigari L; Benassi M; Sarnelli A; Polico R; D'Andrea M
    Med Phys; 2012 Jul; 39(7):4502-14. PubMed ID: 22830782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Control Probability Analysis for Single-Fraction Carbon-Ion Radiation Therapy of Early-Stage Non-small Cell Lung Cancer.
    Paz AE; Yamamoto N; Sakama M; Matsufuji N; Kanai T
    Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1551-1559. PubMed ID: 30076985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha/beta ratio for normal lung tissue as estimated from lung cancer patients treated with stereotactic body and conventionally fractionated radiation therapy.
    Scheenstra AE; Rossi MM; Belderbos JS; Damen EM; Lebesque JV; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):224-8. PubMed ID: 24331668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiation therapy for stage I non-small cell lung cancer: The importance of treatment planning algorithm and evaluation of a tumor control probability model.
    Ohri N; Tomé W; Kalnicki S; Garg M
    Pract Radiat Oncol; 2018; 8(2):e33-e39. PubMed ID: 29233523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal dose and fraction number in SBRT of lung tumours: A radiobiological analysis.
    Ruggieri R; Stavrev P; Naccarato S; Stavreva N; Alongi F; Nahum AE
    Phys Med; 2017 Dec; 44():188-195. PubMed ID: 28130055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiobiological modeling analysis of the optimal fraction scheme in patients with peripheral non-small cell lung cancer undergoing stereotactic body radiotherapy.
    Huang BT; Lu JY; Lin PX; Chen JZ; Li DR; Chen CZ
    Sci Rep; 2015 Dec; 5():18010. PubMed ID: 26657569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of hyper- and hypofractionated radiation schemes with IMRT technique in small cell lung cancer: Clinical outcomes and the introduction of extended LQ and TCP models.
    Li QW; Qiu B; Wang B; Zhang J; Chen L; Zhou Y; Qin JK; Guo SP; Xie WH; Hui ZG; Liang Y; Guo JY; Wang H; Zhu M; Shen WT; Duan LY; Chen LK; Zhang L; Long H; Wang YM; Liu H
    Radiother Oncol; 2019 Jul; 136():98-105. PubMed ID: 31015136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A radiobiological model of reoxygenation and fractionation effects.
    Guerrero M; Carlson DJ
    Med Phys; 2017 May; 44(5):2002-2010. PubMed ID: 28273349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiobiological parameters of liver and lung metastases derived from tumor control data of 3719 metastases.
    Klement RJ
    Radiother Oncol; 2017 May; 123(2):218-226. PubMed ID: 28363484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computed 88% TCP dose for SBRT of NSCLC from tumour hypoxia modelling.
    Ruggieri R; Stavreva N; Naccarato S; Stavrev P
    Phys Med Biol; 2013 Jul; 58(13):4611-20. PubMed ID: 23771131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data?
    Santiago A; Barczyk S; Jelen U; Engenhart-Cabillic R; Wittig A
    Radiat Oncol; 2016 May; 11():67. PubMed ID: 27154064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic Body Radiation Therapy for Spinal Metastases: Tumor Control Probability Analyses and Recommended Reporting Standards.
    Soltys SG; Grimm J; Milano MT; Xue J; Sahgal A; Yorke E; Yamada Y; Ding GX; Li XA; Lovelock DM; Jackson A; Ma L; El Naqa I; Gibbs IC; Marks LB; Benedict S
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):112-123. PubMed ID: 33516580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered fractionation schemes in radiotherapy.
    Stuschke M; Pöttgen C
    Front Radiat Ther Oncol; 2010; 42():150-156. PubMed ID: 19955801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.